Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9184313 | Seminars in Thoracic and Cardiovascular Surgery | 2005 | 4 Pages |
Abstract
Induction chemotherapy has been proven to improve survival in patients with Stage IIIA non-small cell lung cancer, and is under investigation for early stage disease. Controversy still exists regarding the choice of chemotherapy regimens, patient selection, and inclusion of radiation therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
B. Zane MD, Thomas A. MD,